Skip to main content
. 2024 Aug 9;15:6617. doi: 10.1038/s41467-024-50394-x

Fig. 1. Selective serotonin releasing agent is not negated by 5-HT1A supersensitivity, resulting in a rapid onset of pro-serotonergic activity.

Fig. 1

A The majority of central serotonin (5-HT) innervation originates from the dorsal raphe nucleus (lilac), and is found within areas of the brain strongly implicated in mood regulation and cognitive function: amygdala (AMY; yellow), hippocampus (HIP; purple), striatal structures (STRM; green), anterior cingulate cortex (ACC; light blue) and the frontal lobe, including the prefrontal cortex (PFC; red). B Selective serotonin reuptake inhibitors (SSRI) and selective serotonin releasing agents (SSRA) both influence extracellular presynaptic serotonin concentrations, modulating downstream serotonergic activity, while the effects of SSRIs on synaptic 5-HT are delayed by autoreceptor hypersensitivity and may influence colocalised dopamine neurons. C 5-HT1a ARs are clustered in the dorsal raphe nucleus and are endogenously sensitive to extracellular serotonin, and upon activation produce a negative feedback loop which inhibits upstream firing-dependent serotonin release. The original atlas meshes in panel A are credited to A. M. Winkler (Brain For Blender), which have been modified for illustrative purposes, released under a Creative Commons Attribution ShareAlike 3.0 Unported license (https://creativecommons.org/licenses/by-sa/3.0/). Panels B and C were created with BioRender.com and released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license (https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en). AR autoreceptor; GPCR G protein-coupled receptor; LGICR Ligand-gated ion-channel receptors; MAO Monoamine oxidase, SERT serotonin transporter.